Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification

被引：4

作者：

Martinez, Esteban ^{[1
]}

Gatell, Jose M. ^{[1
]}

机构：

[1] Univ Barcelona, IDIBAPS Hosp Clin, Infect Dis Unit, Barcelona, Spain

来源：

AIDS | 2007年 / 21卷 / 13期

关键词：

D O I：

10.1097/QAD.0b013e328133f081

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1829 / 1830

页数：2

共 9 条

[1] Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir
Abgrall, Sophie
Yeni, Patrick G.
Bouchaud, Olivier
Costagliola, Dominique
[J]. AIDS, 2006, 20 (16) : 2099 - 2106
[2] *CHMP, 2005, GUID CLIN DEV MED PR
[3] Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies
MacMahon, S
Collins, R
[J]. LANCET, 2001, 357 (9254) : 455 - 462
[4] Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
Martinez, E
Arnaiz, JA
Podzamczer, D
Dalmau, D
Ribera, E
Domingo, P
Knobel, H
Riera, M
Pedrol, E
Force, L
Llibre, JM
Segura, F
Richart, C
Cortes, C
Javaloyas, M
Aranda, M
Cruceta, A
de Lazzari, E
Gatell, JM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11) : 1036 - 1046
[5] Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients
Martinez, Esteban
Arnaiz, Juan A.
Podzamczer, Daniel
Dalmau, David
Ribera, Esteban
Domingo, Pere
Knobel, Hernando
Leyes, Maria
Pedrol, Enric
Force, Luis
de Lazzari, Elisa
Gatell, Jose M.
[J]. AIDS, 2007, 21 (03) : 367 - 369
[6] Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection
Phillips, AN
Walker, AS
[J]. AIDS, 2004, 18 (03) : 365 - 370
[7] Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials
Phillips, AN
Grabar, S
Tassie, JM
Costagliola, D
Lundgren, JD
Egger, M
[J]. AIDS, 1999, 13 (15) : 2075 - 2082
[8] Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
Phillips, AN
Pradier, C
Lazzarin, A
Clotet, B
Goebel, FD
Hermans, P
Antunes, F
Ledergerber, B
Kirk, O
Lundgren, JD
[J]. AIDS, 2001, 15 (18) : 2385 - 2395
[9] Randomized trials or observational tribulations?
Pocock, SJ
Elbourne, DR
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) : 1907 - 1909

← 1 →